Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glossopharyngeal Nerve Block for GERD-Induced Dysphagia
NCT06304870Not yet recruiting
- Start
- Mar 2024
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine and cyanocobalamin in oropharyngeal dysphagia (2 arms). Primary endpoint: Rosenbek penetration-aspiration scale at day 20. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrinecyanocobalamin
03
Conditions
oropharyngeal dysphagia
Beyond the preview
Go deeper on NCT06304870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06304870.